These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10734837)

  • 1. New drugs to treat irritable bowel syndrome being tested.
    Mayo Clin Health Lett; 2000 Mar; 18(3):4. PubMed ID: 10734837
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 3. Lotronex(tm): therapy for diarrhea predominant irritable bowel syndrome.
    McGahan L
    Issues Emerg Health Technol; 2000 Oct; (11):1-5. PubMed ID: 11902219
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
    Horwitz BJ
    Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel medications for the irritable bowel syndrome: motility and sensation.
    Camilleri M
    J Pediatr Gastroenterol Nutr; 2001; 32 Suppl 1():S35-7. PubMed ID: 11321419
    [No Abstract]   [Full Text] [Related]  

  • 6. [Irritable bowel syndrome as an interdisciplinary clinical challenge. Current views on its pathophysiology, diagnosis and treatment].
    Hollerbach S; Elsenbruch S; Enck P
    Dtsch Med Wochenschr; 2001 Apr; 126(16):472-8. PubMed ID: 11360454
    [No Abstract]   [Full Text] [Related]  

  • 7. Tegaserod and other serotonergic agents: what is the evidence?
    Chey WD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Soon one "female distress" less. Irritable bowel syndrome responds to serotonin blockers].
    MMW Fortschr Med; 2000 Sep; 142(37):55. PubMed ID: 11026224
    [No Abstract]   [Full Text] [Related]  

  • 9. Alosetron: a new therapy for irritable bowel syndrome.
    Kupecz D
    Nurse Pract; 2000 Jul; 25(7):95-6, 98-100. PubMed ID: 10916831
    [No Abstract]   [Full Text] [Related]  

  • 10. [New therapeutic approaches in irritable bowel syndrome].
    Müller-Lissner SA
    Z Gastroenterol; 2000 Sep; 38(9):815-6. PubMed ID: 11072681
    [No Abstract]   [Full Text] [Related]  

  • 11. Irritable bowel syndrome.
    Kennedy T; Rubin G; Jones R
    Clin Evid; 2004 Jun; (11):615-25. PubMed ID: 15652025
    [No Abstract]   [Full Text] [Related]  

  • 12. Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment.
    Olden KW
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S3-7. PubMed ID: 12825862
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin receptor modulation in irritable bowel syndrome: one step forwards and one step backwards.
    Whorwell PJ
    Gut; 2001 May; 48(5):596-7. PubMed ID: 11302953
    [No Abstract]   [Full Text] [Related]  

  • 14. Alosetron (Lotronex) for treatment of irritable bowel syndrome.
    Med Lett Drugs Ther; 2000 Jun; 42(1081):53-4. PubMed ID: 10872030
    [No Abstract]   [Full Text] [Related]  

  • 15. [Irritable bowel syndrome: diagnostic criteria and recent advancement of its pharmacological management].
    Matsueda K
    Nihon Shokakibyo Gakkai Zasshi; 2001 Oct; 98(10):1146-53. PubMed ID: 11680988
    [No Abstract]   [Full Text] [Related]  

  • 16. Contemporary thoughts on the treatment of irritable bowel syndrome.
    Giaquinta D
    Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
    [No Abstract]   [Full Text] [Related]  

  • 17. [New drug for irritable bowel syndrome].
    Hennemann A
    Med Monatsschr Pharm; 2001 Apr; 24(4):106-8. PubMed ID: 11338633
    [No Abstract]   [Full Text] [Related]  

  • 18. Alosetron for irritable bowel syndrome.
    Barbehenn E; Lurie P; Wolfe SM
    Lancet; 2000 Dec; 356(9246):2009-10. PubMed ID: 11130544
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurotransmitter antagonism in management of irritable bowel syndrome.
    Lembo T
    Lancet; 2000 Mar; 355(9209):1030-1. PubMed ID: 10744083
    [No Abstract]   [Full Text] [Related]  

  • 20. Alosetron for irritable bowel syndrome. Senior vice president of GlaxoSmithKline responds.
    Palmer JB
    BMJ; 2003 Jan; 326(7379):51. PubMed ID: 12511473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.